Structural conformation and self-assembly process of p31-43 gliadin peptide in aqueous solution. Implications for celiac disease

FEBS J. 2020 May;287(10):2134-2149. doi: 10.1111/febs.15109. Epub 2019 Nov 23.

Abstract

Celiac disease (CeD) is a highly prevalent chronic immune-mediated enteropathy developed in genetically predisposed individuals after ingestion of a group of wheat proteins (called gliadins and glutenins). The 13mer α-gliadin peptide, p31-43, induces proinflammatory responses, observed by in vitro assays and animal models, that may contribute to innate immune mechanisms of CeD pathogenesis. Since a cellular receptor for p31-43 has not been identified, this raises the question of whether this peptide could mediate different biological effects. In this work, we aimed to characterize the p31-43 secondary structure by different biophysical and in silico techniques. By dynamic light scattering and using an oligomer/fibril-sensitive fluorescent probe, we showed the presence of oligomers of this peptide in solution. Furthermore, atomic force microscopy analysis showed p31-43 oligomers with different height distribution. Also, peptide concentration had a very strong influence on peptide self-organization process. Oligomers gradually increased their size at lower concentration. Whereas, at higher ones, oligomers increased their complexity, forming branched structures. By CD, we observed that p31-43 self-organized in a polyproline II conformation in equilibrium with β-sheets-like structures, whose pH remained stable in the range of 3-8. In addition, these findings were supported by molecular dynamics simulation. The formation of p31-43 nanostructures with increased β-sheet structure may help to explain the molecular etiopathogenesis in the induction of proinflammatory effects and subsequent damage at the intestinal mucosa in CeD.

Keywords: celiac disease; gliadin p31-43 peptide; oligomers; secondary structure; self-assembly.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caco-2 Cells
  • Celiac Disease / drug therapy*
  • Celiac Disease / genetics
  • Celiac Disease / immunology
  • Celiac Disease / pathology
  • Gliadin / genetics
  • Gliadin / immunology
  • Gliadin / pharmacology*
  • Gliadin / ultrastructure
  • Humans
  • Immunity, Innate / drug effects*
  • Immunity, Innate / immunology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / immunology
  • Microscopy, Atomic Force
  • Molecular Conformation / drug effects
  • Peptide Fragments / genetics
  • Peptide Fragments / immunology
  • Peptide Fragments / pharmacology*
  • Peptide Fragments / ultrastructure
  • Peptides / chemistry
  • Peptides / immunology
  • Peptides / pharmacology
  • Protein Conformation, beta-Strand
  • Solutions / chemistry
  • Water / chemistry

Substances

  • Peptide Fragments
  • Peptides
  • Solutions
  • gliadin p31-43
  • Water
  • polyproline
  • Gliadin